This message was sent to ##Email##
|
|
|
|
|
| |
| HEALTH CARE NEWS AND UPDATES |
Medical News Today
Groundbreaking laboratory-grown prostate cancer cells could change the way research is carried out. They will significantly increase the speed at which new drugs can be trialed. Aside from skin cancer, prostate cancer is the most common cancer in the United States, with around 164,000 new cases each year.
READ MORE
News-Medical.Net
The hotspots are specific to E.coli and related bacteria, but the findings could help researchers identify similar parts of human DNA where the risk of mutation is increased.
The risk of cancer arising as a result of these mutations is highest in tissues that have a high rate of cellular renewal (such as bone or prostate) and therefore more opportunity for the errors to arise as DNA is replicated.
READ MORE
|
Promoted by
|
|
|
|
 |
Medical News Today
A new study shows that the cells surrounding the breast's milk ducts form an active barrier that extends and grabs cancer cells before they spread to the rest of the body. The American Cancer Society estimates that in 2017, there were more than 310,000 new cases of breast cancer among American women.
READ MORE
Annals of Internal Medicine
Matching unique features of cancer types with effective therapies is a cornerstone of precision medicine. Clinical success has been seen in inhibiting specific molecular alterations that drive the growth of cancer cells and targeting molecules whose elevated expression is confined to cancer cells. In addition, cancer cells can have vulnerabilities induced by somatic mutations they carry; attacks on these vulnerabilities range from specific molecular alterations pointing to direct drug strategies to harnessing immune recognition of genetically altered epitopes produced by the cancer cells.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
OncLive
The National Comprehensive Cancer Network (NCCN) made history when it updated its glioblastoma treatment guidelines in March. The group became the first learned body to endorse the routine frontline use of an entirely new treatment modality known as tumor-treating fields (TTFs).
READ MORE
The Washington Post
Chi Van Dang generally declines to discuss the science that made him famous.
A leading authority on cancer metabolism, he routinely is asked to speak about how tumors reprogram biochemical pathways to help them slurp up nutrients and how disrupting these noxious adaptations could be a powerful approach to treating cancer.
READ MORE
 |
|
Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast.
Donate today.
|
|
The Conversation
Could the poop of some cancer patients hold the key to treating certain cancers in all people?
What does cancer have to do with poop? In the past few years, researchers around the world, including us, have realized that the gut bacteria — what we call the gut microbiome — of cancer patients may hold the key to improving cancer therapies for patients. Exactly how this happens is unclear, but may be linked to the ability of gut bacteria to boost our natural immune responses.
READ MORE
Science Trends
A human body contains about 37 trillion cells that originated from a single zygote. This developmental process is precisely controlled by thousands of genes to ensure each cell follows the proper cell fate during replication. However, no machine has a zero failure rate. When this cellular machinery is disrupted, cells might lose control and grow unlimitedly which eventually leads to cancer. The huge number of cancer-related genes make the pathology extremely complicated.
READ MORE
ScienceDaily
Cancer cells are known to acidify their environment and, consequently, the interior of the cells themselves is alkalized. In principle, this deregulation should hinder the development and proliferation of these cells. However, exactly the opposite happens in cancer. A computational study co-authored by computational chemist Miquel Duran-Frigola, from the Institute for Research in Biomedicine (IRB Barcelona), has demonstrated that cancer cells proliferate less and in a less robust manner when their internal pH is lowered, that is to say it becomes more acidic.
READ MORE
| ACS CANCER PROGRAMS UPDATES |
ACS
If you are a dynamic and forward thinking individual this career opportunity is for you! This awesome position is located in Chicago. We want you to join our great accreditation team as a technical specialist. In this role you will support, evaluate, interpret and clarify accreditation standards and facility activities for multiple cancer accreditation programs. This position will ensure accurate and consistent evaluation of current accreditation program standards through technical survey reviews, including oversight of performance reports, resolutions and accredited program support. This position is also responsible for developing and disseminating educational activities concerning cancer program activities and standard interpretation, including, but not limited to educational workshops and webinars, the CAnswer Forum and online resources.
If you have excellent communication skills, a high level of energy, thrive in a fast-paced environment and have a strong desire to continue our mission of providing excellent customer support we want you to apply!
To review this career opportunity in detail and to apply, please click here.
Clinical Research Program
As mentioned in prior communications, the 2018 DCIS Special Study is opening July 16. We invite you to visit the 2018 Special Study on DCIS SharePoint site, which will house all materials you will need to participate in the study. We have created a universal login for this site; please note it is case sensitive:
Login: DCISStudy
Password: study2018.
All registrars and co-registrars will be able to access and download materials via the SharePoint site.
READ MORE
ACS
The American College of Surgeons (ACS) 2018 Cancer Programs Annual Conference: Learn. Interact. Transform provides cutting-edge solutions to help you deliver high-quality, patient-centered, multidisciplinary care to patients with cancer. Through a combination of plenaries, breakout sessions and networking opportunities you will leave this conference reinvigorated and ready to overcome the challenges facing you as a cancer care provider.
Detailed information, as well as conference agenda, can be found on the Cancer Programs Annual Conference website.
Register now to take advantage of the early-bird registration fee and SAVE.
READ MORE
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
ACS
The National Cancer Database (NCDB) is pleased to announce that the Participant User File (PUF) application will be open through Aug. 6. The NCDB will accept applications for site-specific files, which include cases diagnosed between 2004 and 2015. The 2016 PUF, which will include 2004-2016 diagnosis years, will be available for request during the next application period, January 2019.
The NCDB PUF is a Health Insurance Portability and Accountability Act (HIPAA) compliant data file containing cases submitted to the Commission on Cancer's (CoC) NCDB and complies with the terms of the Business Associate Agreement between the American College of Surgeons and cancer programs accredited by the CoC; i.e., no patients or facilities can be identified. The PUF is designed to provide investigators at CoC-accredited cancer programs with a data resource they can use to review and advance the quality of care delivered to cancer patients through analyses of cases reported to the NCDB.
For more information, review the PUF Website.
Questions regarding the NCDB PUFs or the RFA process for a PUF may be directed to NCDB technical staff at NCDB_PUF@facs.org.
ACS
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the most appropriate care plan.
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
This corrected third printing includes the following features:
- Revised breast cancer staging system
- Revised histology codes in each chapter
- Corrected errata posted on www.cancerstaging.org through Feb. 2.
Special 25 percent discount! Expires Oct. 30.
Click here for the Springer order form.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
®: Cancer Data at Your Fingertips